AI assistant
Invalda INVL Board/Management Information 2021
2247_rns_2021-04-08_a4bd6c97-597a-423e-9353-368a35758038.pdf
Board/Management Information
Open in viewerOpens in your device viewer
INVALDA
INVL
CANDIDATES TO THE AUDIT COMMITTEE OF INVALDA INVL:
| Educational background and qualifications | Owned number of shares in Invalda INVL | Work experience | |
|---|---|---|---|
 |
|||
| Dangutė Pranckėnienė | |||
| Independent audit committee member | Vilnius Gediminas Technical University, Master of Business Administration. | ||
| Vilnius University, Master of Economics. | |||
| The International Coach Union (ICU), professional coucher name. | |||
| Lithuanian Ministry of Finance, the auditor's name. | - | Since 1997 the Partner at Moore Mackonis, UAB | |
| 1996 - 1997 Audit Manager, Deloitte & Touche | |||
| 1995 - 1996 Lecturer, Vilnius Gediminas Technical University | |||
| 1982 - 1983 Lecturer, Vilnius University | |||
 |
|||
| Tomas Bubinas | |||
| Independent audit committee member | Baltic Management Institute (BMI), Executive MBA | ||
| Association of Chartered Certified Accountants. ACCA. Fellow Member | |||
| Lithuanian Sworn Registered Auditor | |||
| Vilnius University, Master of economics | - | Since 2013 Chief Operating Officer of Biotechpharma, UAB. | |
| 2010 - 2012 Senior Director of TEVA Biopharmaceuticals (USA). | |||
| 2004-2010 - TEVA Pharmaceuticals, Chief Financial Officer for the Baltic States. | |||
| 2001-2004 - Sicor Biotech, Chief Financial Officer | |||
| 1999 - 2001 Senior Manager of PricewaterhouseCoopers. | |||
| 1994 - 1999 Senior Auditor, Manager of Coopers & Lybrand. |